Topical application of ozonated sunflower oil accelerates the healing of lesions of cutaneous leishmaniasis in mice under meglumine antimoniate treatment
Medical Microbiology and Immunology · 2024-12 · 213 (1)
DOI: 10.1007/s00430-024-00788-x ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Microbiology and Immunology, online erschienen am 27.03.2024. Verfasst von Ana Paula Pivotto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Laboratory of Applied Immunology, Center of Medical and Pharmaceutical Sciences, Western Parana State University, Cascavel, PR, Zip Code 85819-110, B…. Hauptthemen laut MEDLINE: Antiprotozoal Agents, Leishmaniasis, Cutaneous, Ozone. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Fundação Araucária.
Abstract (Originalsprache)
Besides being scarce, the drugs available for treating cutaneous leishmaniasis have many adverse effects. Ozone is an option to enhance the standard treatment due to the wound-healing activity reported in the literature. In this study, we evaluated the efficiency of ozonated sunflower oil as an adjuvant in treating cutaneous lesions caused by Leishmania amazonensis. BALB/c mice were infected with L. amazonensis, and after the lesions appeared, they were treated in four different schedules using the drug treatment with meglumine antimoniate (Glucantime®), with or without ozonated oil. After thirty days of treatment, the lesions' thickness and their parasitic burden, blood leukocytes, production of NO and cytokines from peritoneal macrophages and lymph node cells were analyzed. The group treated with ozonated oil plus meglumine antimoniate showed the best performance, improving the lesion significantly. The parasitic burden showed that ozonated oil enhanced the leishmanicidal activity of the treatment, eliminating the parasites in the lesion. Besides, a decrease in the TNF levels from peritoneal macrophages and blood leukocytes demonstrated an immunomodulatory action of ozone in the ozonated oil-treated animals compared to the untreated group. Thus, ozonated sunflower oil therapy has been shown as an adjuvant in treating Leishmania lesions since this treatment enhanced the leishmanicidal and wound healing effects of meglumine antimoniate.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Laboratory of Applied Immunology, Center of Medical and Pharmaceutical Sciences, Western Parana State University, Cascavel, PR, Zip Code 85819-110, Brazil.
- Laboratory of Microbiology, Western Parana University Hospital, Western Parana State University, Cascavel, PR, Brazil.
- Laboratory of Applied Immunology, Center of Medical and Pharmaceutical Sciences, Western Parana State University, Cascavel, PR, Zip Code 85819-110, Brazil. rafael.menolli@unioeste.br.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Fundação Araucária
Zitieren
APA
Pivotto, A. P., de Souza Lima, L. B., Michelon, A., Ferreira, C. Z. P., Gandra, R. F., Ayala, T. S., & Menolli, R. A. (2024). Topical application of ozonated sunflower oil accelerates the healing of lesions of cutaneous leishmaniasis in mice under meglumine antimoniate treatment. Medical Microbiology and Immunology, 213(1). https://doi.org/10.1007/s00430-024-00788-x
Vancouver
Pivotto AP, de Souza Lima LB, Michelon A, Ferreira CZP, Gandra RF, Ayala TS, et al. Topical application of ozonated sunflower oil accelerates the healing of lesions of cutaneous leishmaniasis in mice under meglumine antimoniate treatment. Medical Microbiology and Immunology. 2024;213(1). doi:10.1007/s00430-024-00788-x
BibTeX
@article{Pivotto2024,
author = {Pivotto, Ana Paula and de Souza Lima, Lucas Bonatto and Michelon, Alexandra and Ferreira, Camilla Zottesso Pellon and Gandra, Rinaldo Ferreira and Ayala, Thaís Soprani and Menolli, Rafael Andrade},
title = {Topical application of ozonated sunflower oil accelerates the healing of lesions of cutaneous leishmaniasis in mice under meglumine antimoniate treatment},
journal = {Medical Microbiology and Immunology},
year = {2024},
volume = {213},
number = {1},
doi = {10.1007/s00430-024-00788-x}
}
EUVIMED